AGP Picks
View all

Technology Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.

Press releases published on July 23, 2026

Ocean Power Technologies Acquires Strategic Subsea Technology to Expand Operational Infrastructure Supporting Maritime Dominance
Navitas and Magnachip Announce Strategic Partnership to Accelerate High-Voltage and Ultra-High-Voltage Silicon Carbide Adoption
Oriental Culture Holding LTD. Announces Strategic Transition to Supporting Services for Third Party Art and Collectible Platforms
Merlin to Report Second Quarter 2026 Results on August 13, 2026
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience
UPDF Launches New Research Hub to Help PhD Candidates, Students, and Researchers Work Smarter
Comstock Announces Second Quarter 2026 Business Results and Outlook
Crescent Biopharma Announces Grants of Inducement Awards
Ocean Power Technologies Announces Fourth Quarter and Full Year Fiscal 2026 Results
Turtle Beach Corporation to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Codexis Announces Proposed Public Offering of Common Stock
DoubleVerify to Announce Second Quarter 2026 Financial Results on August 6, 2026
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Silvaco Announces Date of Second Quarter 2026 Financial Results Conference Call
Rigetti Computing to Report Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.